Researchers at Cleveland Clinic Children's have introduced a new screening program for congenital cytomegalovirus (CMV), the most common infection transmitted from mothers to babies during pregnancy. The program expands on standard newborn screening to detect the virus in infants who might otherwise go unnoticed.
While many babies with congenital CMV show no clear symptoms at birth, a subset can experience serious long-term consequences, including hearing loss and developmental delays. The new screening approach aims to identify these cases early, allowing for closer follow-up and potential treatment before problems become apparent.
Because the source describes only this single initiative, there are no conflicting findings to compare. The program represents a step toward broader routine screening for a condition that is often underdiagnosed due to its silent presentation in newborns.